CalciMedica, Inc. (CALC)Healthcare | Biotechnology | La Jolla, United States | NasdaqCM
0.46 USD
-0.01
(-1.191%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.48 +0.01 (2.584%) ⇧ (Aug. 28, 2026, 7:47 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:12 a.m. EDT
The immediate outlook is severely clouded by a relentless downward price trend and deteriorating financial health. Over the last two weeks, the stock has tumbled from $0.80 to $0.57, reflecting a sharp loss of momentum and investor confidence. This recent crash is underpinned by a broader structural decline: the asset has lost 33% of its value year-over-year and is trading at a significant discount to its 200-day moving average, indicating deep technical weakness. Fundamentally, the company is in distress, reporting negative earnings, negative free cash flow, and a negative return on equity, while facing a negative forward P/E that suggests analysts see no near-term profitability. Although the balance sheet currently shows a healthy current ratio, this is likely propped up by cash reserves rather than operational strength, given the burning cash. There is no dividend to provide any cushion for income investors. While the price-to-book ratio appears low, it reflects the market's skepticism about the business's ability to generate future value rather than a genuine bargain. The combination of falling revenues, negative cash generation, and a collapsing stock price makes this a high-risk speculative vehicle unsuitable for investment. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.194798 |
| MSTL | 0.197138 |
| AutoETS | 0.202662 |
| AutoARIMA | 0.204709 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 0.23 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.829 |
| Excess Kurtosis | -0.40 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 166.878 |
| Market Cap | 3,171,058 |
| Forward P/E | -0.28 |
| Beta | 1.12 |
| Website | https://calcimedica.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8503226 |
| Address1 | 505 Coast Boulevard South |
| Address2 | Suite 307 |
| All Time High | 8.59 |
| All Time Low | 0.44 |
| Ask | 0.5915 |
| Ask Size | 1 |
| Audit Risk | 7 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 477,370 |
| Average Daily Volume3 Month | 1,359,561 |
| Average Volume | 1,359,561 |
| Average Volume10Days | 477,370 |
| Beta | 1.124 |
| Bid | 0.6483 |
| Bid Size | 1 |
| Board Risk | 8 |
| Book Value | 0.179 |
| City | La Jolla |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.4644 |
| Current Ratio | 5.577 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.4753 |
| Day Low | 0.44 |
| Debt To Equity | 166.878 |
| Display Name | CalciMedica |
| Earnings Timestamp End | 1,755,288,000 |
| Earnings Timestamp Start | 1,754,942,400 |
| Ebitda | -19,595,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.329 |
| Enterprise Value | 6,438,294 |
| Eps Forward | -1.63 |
| Eps Trailing Twelve Months | -6.78 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.74462 |
| Fifty Day Average Change | -0.28022003 |
| Fifty Day Average Change Percent | -0.3763262 |
| Fifty Two Week Change Percent | -85.03226 |
| Fifty Two Week High | 7.2 |
| Fifty Two Week High Change | -6.7356 |
| Fifty Two Week High Change Percent | -0.9355 |
| Fifty Two Week Low | 0.44 |
| Fifty Two Week Low Change | 0.024399996 |
| Fifty Two Week Low Change Percent | 0.055454537 |
| Fifty Two Week Range | 0.44 - 7.2 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,686,749,400,000 |
| Float Shares | 18,954,314 |
| Forward Eps | -1.63 |
| Forward P E | -0.28490797 |
| Free Cashflow | -10,536,625 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 16 |
| Fullday Change | -0.00560001 |
| Fullday Change Percent | -1.19149 |
| Fullday Price | 0.4764 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.18530001 |
| Held Percent Institutions | 0.57512003 |
| Implied Shares Outstanding | 6,828,292 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,023-06-14 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California. |
| Long Name | CalciMedica, Inc. |
| Market | us_market |
| Market Cap | 3,171,058 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_34235142 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -21,240,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 14,415,372 |
| Number Of Analyst Opinions | 3 |
| Open | 0.4661 |
| Operating Cashflow | -19,106,000 |
| Operating Margins | 0.0 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 858 952 5500 |
| Post Market Change | 0.0119999945 |
| Post Market Change Percent | 2.5839782 |
| Post Market Price | 0.4764 |
| Post Market Time | 1,787,960,840 |
| Previous Close | 0.47 |
| Price Hint | 4 |
| Price To Book | 2.5944133 |
| Profit Margins | 0.0 |
| Quick Ratio | 5.334 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.5 |
| Region | US |
| Regular Market Change | -0.00560001 |
| Regular Market Change Percent | -1.19149 |
| Regular Market Day High | 0.4753 |
| Regular Market Day Low | 0.44 |
| Regular Market Day Range | 0.44 - 0.4753 |
| Regular Market Open | 0.4661 |
| Regular Market Previous Close | 0.47 |
| Regular Market Price | 0.4644 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 673,782 |
| Return On Assets | -0.63584 |
| Return On Equity | -3.6570199 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 6,828,292 |
| Shares Percent Shares Out | 0.0095 |
| Shares Short | 64,648 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 192,146 |
| Short Name | CalciMedica, Inc. |
| Short Percent Of Float | 0.0139 |
| Short Ratio | 1.08 |
| Source Interval | 15 |
| State | CA |
| Symbol | CALC |
| Target High Price | 15.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 10.0 |
| Target Median Price | 9.0 |
| Total Cash | 18,617,000 |
| Total Cash Per Share | 0.545 |
| Total Debt | 9,200,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -6.78 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.78906 |
| Two Hundred Day Average Change | -1.3246601 |
| Two Hundred Day Average Change Percent | -0.74042237 |
| Type Disp | Equity |
| Volume | 673,782 |
| Website | https://calcimedica.com |
| Zip | 92,037 |